The estimated Net Worth of Dov Perlysky is at least $227 ezer dollars as of 14 January 2019. Mr. Perlysky owns over 9,184 units of Enzo Biochem stock worth over $73,024 and over the last 12 years he sold ENZ stock worth over $0. In addition, he makes $154,375 as Lead Independent Director at Enzo Biochem.
Dov has made over 3 trades of the Enzo Biochem stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 9,184 units of ENZ stock worth $24,797 on 14 January 2019.
The largest trade he's ever made was exercising 59,455 units of Enzo Biochem stock on 31 October 2017 worth over $171,230. On average, Dov trades about 5,617 units every 31 days since 2013. As of 14 January 2019 he still owns at least 65,787 units of Enzo Biochem stock.
You can see the complete history of Mr. Perlysky stock trades at the bottom of the page.
Dov Perlysky CPA serves as Lead Independent Director of the Company. He is currently a member of the Company’s Audit, Compensation and Nominating/Governance Committees. Mr. Perlysky became the chairman of the Compensation Committee in 2017. Mr. Perlysky has been a member of the Board of Directors of Pharma-Bio Serv, Inc. since 2004, and was a former Director of Highlands State Bank until their sale to Lakeland Bank. Mr. Perlysky has also been the managing member of Nesher, LLC, a private investment firm, since 2000 and was a director of Engex, Inc., a closed-end mutual fund and News Communications. Mr. Perlysky was a vice president in the private client group of Laidlaw Global Securities, a registered broker-dealer. Mr. Perlysky received his Bachelor of Science in Mathematics and Computer Science from the University of Illinois in 1985 and his Master of Management from the J.L. Kellogg School of Management of Northwestern University in 1991. ), other current and past board positions and finance background, making him well qualified as a member of our Board.
As the Lead Independent Director of Enzo Biochem, the total compensation of Dov Perlysky at Enzo Biochem is $154,375. There are 9 executives at Enzo Biochem getting paid more, with Elazar Rabbani having the highest compensation of $1,487,800.
Dov Perlysky is 58, he's been the Lead Independent Director of Enzo Biochem since 2019. There are 5 older and 8 younger executives at Enzo Biochem. The oldest executive at Enzo Biochem, Inc. is Dr. Elazar Rabbani Ph.D., 78, who is the Co-Founder, Chairman, Chief Scientific Officer & Sec..
Dov's mailing address filed with the SEC is C/O ENZO BIOCHEM, INC., 527 MADISON AVENUE, NEW YORK, NY, 10022.
Over the last 22 years, insiders at Enzo Biochem have traded over $2,615,763 worth of Enzo Biochem stock and bought 1,070,494 units worth $3,103,461 . The most active insiders traders include Bradley Louis Radoff, Management Corp Harbert Dis... és Elazar Rabbani. On average, Enzo Biochem executives and independent directors trade stock every 127 days with the average trade being worth of $59,099. The most recent stock trade was executed by Kara Cannon on 21 February 2024, trading 10,640 units of ENZ stock currently worth $11,810.
enzo biochem inc is a financial services company located in 60 executive blvd, farmingdale, new york, united states.
Enzo Biochem executives and other stock owners filed with the SEC include: